Literature DB >> 34889357

Evidence-Based Minireview: For overweight or obese persons with hemophilia A, should factor VIII dosing be based on ideal or actual body weight?

Nicoletta Machin1,2, Ming Y Lim3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34889357      PMCID： PMC8791112          DOI： 10.1182/hematology.2021000317

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN： 1520-4383


× No keyword cloud information.
  15 in total

1.  Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients.

Authors:  Séverine Henrard; Niko Speybroeck; Cedric Hermans
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

Review 2.  Using pharmacokinetics to individualize hemophilia therapy.

Authors:  Alfonso Iorio
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Calculating the dose of factor VIII in the management of haemophilia.

Authors:  G I Ingram
Journal:  Br J Haematol       Date:  1981-06       Impact factor: 6.998

Review 4.  Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.

Authors:  S Björkman; E Berntorp
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Pharmacokinetic analysis of anti-hemophilic factor in the obese patient.

Authors:  A Graham; K Jaworski
Journal:  Haemophilia       Date:  2013-11-20       Impact factor: 4.287

6.  Comparative pharmacokinetics of factor VIII and recombinant factor IX: for which coagulation factors should half-life change with age?

Authors:  S Björkman
Journal:  Haemophilia       Date:  2013-11       Impact factor: 4.287

7.  Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A.

Authors:  Andreas Tiede; Ana Rosa Cid; Georg Goldmann; Victor Jiménez-Yuste; Michael Pluta; Toshko Lissitchkov; Marcus May; Irina Matytsina; Predrag Miljic; Ingrid Pabinger; Paula Persson
Journal:  Thromb Haemost       Date:  2019-12-30       Impact factor: 5.249

8.  Impact of being overweight on factor VIII dosing in children with haemophilia A.

Authors:  S Henrard; C Hermans
Journal:  Haemophilia       Date:  2015-11-11       Impact factor: 4.287

9.  Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open-label, 3 × 3 crossover trial.

Authors:  Craig D Seaman; Jonathan G Yabes; Christina M Lalama; Margaret V Ragni
Journal:  Haemophilia       Date:  2021-03-22       Impact factor: 4.287

10.  Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients.

Authors:  Iris van Moort; Tim Preijers; Hendrika C A M Hazendonk; Roger E G Schutgens; Britta A P Laros-van Gorkom; Laurens Nieuwenhuizen; Felix J M van der Meer; Karin Fijnvandraat; Frank W G Leebeek; Karina Meijer; Ron A A Mathôt; Marjon H Cnossen
Journal:  Br J Clin Pharmacol       Date:  2020-12-16       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.